About us
Product
- API
- Ivabradine hydrochlorid
- Rivaroxaban
- Apixaban
- Dabigatran etexilate
- Safinamide
- Ticlopidine hydrochloride
- Mirtazapine
- Clopidogrel bisulfate
- Duloxetine hydrochloride
- Rebamipide
- Intermediates
- Duloxetine intermediate
- Clopidogrel intermediate
- Mirtazapine intermediates
- Dabigatran etexilate intermediates
- Lurasidone intermediates
- Bepotastine intermediates
- Asenapine Intermediates
- Drotaverine intermediates
- Prasugrel Intermediates
- Ivabradine、Verapamil, Denopamine intermediates
- Moxifloxacin intermediate
- Ticagrelor intermediate <Under Development>
- Canagliflozin intermediate
- Ivabradine intermediate
Address: Zhejiang Provincial Chemical and Medical Raw Material Base Linhai Zone, Duqiao Town, Linhai City, Zhejiang Province, 317016, China
Tel / Fax: 0576-85588211
Tel / Fax: 0576-85588211
CertificatesInspected by local authority, Zhejiang Province Food and Drug Administration, on GMP compliance
Inspected by local authority, Zhejiang Province Food and Drug Administration, on GMP compliance, and issued The “Drug Manufacturing Enterprise Licence” on Nov. 7, 2005. Licence No.: ZHE Ha20050650. The scope includes Ticlopidine Hydrochloride.
[Return]
